r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

PQ

Paul T. Quinlan

Insider · General Counsel · ORKA

Paul T. Quinlan files insider transactions with the SEC as a general counsel of Oruka Therapeutics (ORKA). We hold 3 disclosed purchases and sales filed since 12 January 2012, 2 of them in the last 90 days.

  • Files forORKA
  • Disclosed buys and sells3 in all, 2 in the last 90 days
  • Last disclosure14 August 2026

Positions held

4 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 22 January 2025 — 14 August 2026General Counsel · Oruka Therapeutics (ORKA)18 Form 4 lines · source: SEC Form 4
  • Filed 24 January 2018 — 22 March 2024General Counsel · CymaBay Therapeutics (CBAY)49 Form 4 lines · source: SEC Form 4
  • Filed 13 September 2016 — 9 March 2017General Counsel · TerraVia Holdings (TVIA)7 Form 4 lines · source: SEC Form 4
  • Filed 12 January 2012 — 10 March 2016General Counsel · Solazyme (SZYM)111 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.